Quick Takeaways
- FMR LLC filed SCHEDULE 13G/A for MOONLAKE IMMUNOTHERAPEUTICS CLASS A COMMON STOCK (MLTX).
- Disclosed ownership: 1.1%.
- Date of event: 30 Sep 2025.
FMR LLC - 30 Sep 2025 SCHEDULE 13G/A Report for MOONLAKE IMMUNOTHERAPEUTICS CLASS A COMMON STOCK (MLTX)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Symbol
- MLTX
- Shares outstanding
- 66,084,666 shares
- Disclosed Ownership
- 726,931 shares
- Ownership
- 1.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Nov 2025, 11:40:14 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 06 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 1.1% ownership in MOONLAKE IMMUNOTHERAPEUTICS CLASS A COMMON STOCK (MLTX) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 06 Aug 2025.
- Current filing was accepted on 05 Nov 2025, 11:40.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 1.1% | 726,931 | 724,892 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 1.1% | 726,931 | 0 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** |